D-0329-2023 Class III Terminated
FDA drug recall D-0329-2023 was initiated by Advantice Health, Llc on Feb 2, 2023 and is designated Class III. Reason for recall: Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing. The recall status is terminated (terminated Oct 31, 2023). Affected quantity: 16,152 cans/673 cases.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 1, 2023
- Initiation Date
- Feb 2, 2023
- Termination Date
- Oct 31, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16,152 cans/673 cases
Product description
Dermoplast FIRST AID ANTIBACTERIAL SPRAY (Benzethonium chloride 0.2% First aid antiseptic, Benzocaine 20%) Topical analgesic, NET WT. 2.75 oz (78 g), Distributed by Advantice Health, LLC Cedar Knolls, NJ 07927, NDC# 16864-670-01
Reason for recall
Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.
Distribution pattern
Product was distributed via the internet, distributors and retailers nationwide.
Code information
Lot # 22336A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0329-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026